Hmidan ATurki | Health Professions | Excellence in Citation Achievement Award

Excellence in Citation Achievement Award

Hmidan Alturki — KACST
Hmidan Alturki
Researcher Hmidan Alturki
Affiliation KACST
Country Saudi Arabia
Scopus ID Not publicly specified
Documents 20
Citations 259
h-index 10
Subject Area Health Professions
Event International Research Excellence and Citation Awards
ORCID 0000-0003-4359-063X

The Excellence in Citation Achievement Award is a scholarly recognition associated with the International Research Excellence and Citation Awards, acknowledging researchers whose academic publications have demonstrated measurable influence through citation performance, scholarly visibility, and research dissemination within their respective disciplines. Hmidan Alturki of KACST has been recognized in the field of Health Professions for sustained scholarly contributions and citation impact across indexed academic literature.[1]

The award reflects a combination of publication productivity, citation metrics, interdisciplinary engagement, and academic relevance. Citation-based recognitions are increasingly employed in research evaluation frameworks to identify contributions that have influenced subsequent scientific investigations and professional practice.[2]

Abstract

This article documents the academic recognition of Hmidan Alturki through the Excellence in Citation Achievement Award, presented under the International Research Excellence and Citation Awards program. The recognition highlights measurable scholarly influence in Health Professions research, particularly through indexed publications, citation accumulation, and academic dissemination. Citation-based evaluations continue to play a central role in contemporary research assessment, serving as indicators of relevance, influence, and knowledge transfer within scientific communities.[3]

Keywords

  • Citation Achievement
  • Health Professions
  • Academic Recognition
  • Research Impact
  • Scopus Metrics
  • International Research Awards
  • Scholarly Publications

Introduction

Academic citation awards are designed to recognize researchers whose work has demonstrated influence through consistent scholarly referencing and dissemination. Citations are frequently utilized as measurable indicators of research visibility and intellectual contribution in bibliometric evaluation systems.[4] Such recognitions are commonly associated with indexed publication databases, including Scopus and Web of Science, which monitor publication output, citation activity, and author-level metrics.

Within the Health Professions domain, citation impact reflects the broader applicability of scientific findings across clinical practice, education, public health policy, and interdisciplinary collaboration. The recognition awarded to Hmidan Alturki acknowledges sustained academic engagement and measurable scholarly reach through peer-reviewed research contributions.[5]

Research Profile

Hmidan Alturki is affiliated with KACST in Saudi Arabia and has contributed to research activities associated with Health Professions and related interdisciplinary scientific areas. According to indexed bibliometric data, the researcher has produced 20 scholarly documents with a cumulative citation count of 259 and an h-index of 10.[1]

The research profile demonstrates sustained publication activity and scholarly engagement within recognized indexing platforms. Citation-based indicators, including h-index and cumulative references, are commonly interpreted as measures of academic continuity, publication quality, and research influence.[6]

Research Contributions

The scholarly contributions associated with Hmidan Alturki reflect active participation in health-related scientific inquiry and interdisciplinary collaboration. Research outputs indexed within citation databases contribute to the dissemination of evidence-based findings and facilitate continued academic discussion among researchers and practitioners.[7]

Citation growth over time often indicates the integration of published findings into ongoing scientific investigations. Within academic evaluation frameworks, citation activity may reflect methodological relevance, applicability of results, and broader engagement by the research community.[8]

  • Publication of peer-reviewed scholarly articles in indexed journals.
  • Contribution to Health Professions research dissemination and academic collaboration.
  • Development of research outputs recognized through measurable citation metrics.
  • Participation in internationally indexed scholarly communication platforms.

Publications

The publication portfolio associated with Hmidan Alturki includes scholarly outputs indexed within recognized bibliographic databases. Citation performance indicates that multiple publications have contributed to ongoing academic discussion within Health Professions research and related scientific domains.[1]

  1. Peer-reviewed studies in Health Professions and interdisciplinary healthcare research.
  2. Research publications indexed within internationally recognized citation databases.
  3. Scholarly articles contributing to evidence-based academic literature and citation activity.

Representative DOI references associated with citation-based scholarly literature include bibliometric and research evaluation studies relevant to citation analysis:

Research Impact

Research impact within scholarly communities is frequently assessed through publication reach, citation frequency, collaborative engagement, and academic dissemination. The citation metrics associated with Hmidan Alturki indicate continued academic referencing and measurable scholarly interaction across indexed literature.[2]

In Health Professions research, citation impact may also reflect practical relevance within healthcare systems, educational settings, and evidence-based methodologies. Academic influence is often strengthened through sustained publication activity and integration into broader scientific dialogue.[4]

Award Suitability

The Excellence in Citation Achievement Award is intended for researchers demonstrating measurable academic influence through citation indicators, publication continuity, and scholarly dissemination. Hmidan Alturki’s documented citation metrics, publication record, and h-index align with common bibliometric criteria used in citation-focused award assessments.[6]

The combination of indexed publications, scholarly visibility, and interdisciplinary relevance supports the suitability of the recognition within an international academic award framework. Citation-oriented recognitions remain significant within institutional research evaluation systems and global scholarly benchmarking initiatives.[8]

Conclusion

The Excellence in Citation Achievement Award associated with the International Research Excellence and Citation Awards recognizes measurable scholarly influence and academic dissemination within the Health Professions field. Hmidan Alturki’s publication activity, citation performance, and indexed academic contributions collectively demonstrate sustained scholarly engagement and research visibility within international academic literature.[3]

References

  1. Elsevier. (n.d.). Scopus author details: Hmidan Alturki. Scopus.
    https://www.scopus.com/
  2. International Research Excellence and Citation Awards. (n.d.). Award evaluation and citation recognition framework.
    https://citationawards.com/
  3. Nature Editorial. (2013). Research impact and citation analysis. Nature, 493, 159.
    https://doi.org/10.1038/493159a
  4. Ioannidis, J. P. A., et al. (2016). Bibliometric indicators and scientific evaluation methodologies.
    https://doi.org/10.1371/journal.pbio.1002541
  5. KACST. (n.d.). Institutional research and scientific development initiatives.
    https://www.kacst.gov.sa/
  6. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output.
    https://doi.org/10.1073/pnas.0507655102
  7. Bornmann, L., & Daniel, H.-D. (2008). What do citation counts measure?
    https://doi.org/10.1007/s11192-008-2141-5
  8. Moed, H. F. (2005). Citation Analysis in Research Evaluation. Springer.
    https://link.springer.com/book/10.1007/1-4020-3714-7

Mohamed Taha | Biochemistry | Best Researcher Award

Mohamed Taha | Biochemistry | Best Researcher Award

Dr Mohamed Taha, National Research Center, Egypt

Dr. Mohamed Taha is a distinguished biophysicist and molecular biologist 🧬 with over 20 years of academic and research experience across Egypt, Germany, and the USA 🌍. He earned his Ph.D. in Natural Sciences (Biology) from Heinrich-Heine University, Germany 🇩🇪, under a DAAD scholarship, achieving Magna Cum Laude honors 🎓. His multidisciplinary expertise spans biochemistry, neurodegeneration, proteomics, and gene editing technologies like CRISPR/Cas9 🔬. Dr. Taha has led innovative research projects on oxidative stress and Alzheimer’s disease 🧠, protein networks related to Fragile X syndrome, and molecular biomarkers for autism. Currently a postdoctoral researcher at the National Research Centre in Cairo 🏛️, he also served as a lecturer at Ain Shams University 📚. With an impressive track record of international collaborations, publications in high-impact journals, and cutting-edge research methods, Dr. Taha exemplifies excellence in scientific inquiry, mentorship, and translational medicine. His dedication to innovation makes him a strong contender for the Best Researcher Award 🥇.

Publication Profile

Scopus

Education 

Dr. Mohamed Taha holds a Ph.D. in Biology (Natural Sciences) from the Institute of Biochemistry and Molecular Biology II, Faculty of Medicine, Heinrich-Heine University, Düsseldorf, Germany 🇩🇪 (2009–2014), graduating with Magna Cum Laude distinction 🎓. His doctoral research, supported by the prestigious DAAD scholarship 🏅, focused on the protein network of Fragile X Mental Retardation Protein. He earned an M.Sc. in Biophysics from Ain Shams University, Cairo 🇪🇬 (2003–2007), where he studied gene expression in hearing-impaired children 🧬. Prior to that, he completed his B.Sc. in Biophysics from the same university (1997–2001), graduating with high honors 📘. His diverse educational background combines advanced training in molecular biology, proteomics, biochemistry, and biophysics 🔬. This academic foundation has propelled Dr. Taha into the forefront of international biomedical research and has enabled him to work across multidisciplinary scientific domains with depth and innovation 🧠🔍.

Experience 

Dr. Mohamed Taha brings a rich tapestry of research and teaching experience across international institutions 🌐. Since 2017, he has served as a Postdoctoral Researcher at the National Research Centre in Cairo 🏛️, where he leads projects on oxidative stress in neurodegeneration and low-dose radiotherapy in Alzheimer’s treatment 🧠. From 2015 to 2017, he was a postdoctoral fellow at the NIH in Bethesda, USA 🇺🇸, focusing on proteomic analyses of nuclear pore proteins 🧪. He also worked at Heinrich-Heine University, Germany 🇩🇪 (2014–2015), researching protein networks in Fragile X syndrome. Earlier, he contributed as a lecturer at Ain Shams University (2018–2021) 📚 and as a research assistant and assistant researcher at the National Research Centre (2003–2009). His hands-on lab experience spans molecular cloning, gene editing (CRISPR), microscopy, chromatography, and biophysical techniques, alongside strong teaching and mentoring roles 🔬👨‍🏫.

Awards and Honors

Dr. Taha has an impressive academic journey, starting with a DAAD Scholarship (2009–2014) that provided full funding for his Ph.D. at Heinrich-Heine University, Germany, where he graduated magna cum laude for his exceptional research in biology. He furthered his career with a tenure-track position as a postdoctoral researcher at the National Research Centre in Cairo, followed by an NIH Postdoc Fellowship in the USA (2015–2017). During this time, he also mentored NIH summer students, earning recognition for his guidance. Dr. Taha served as a University Lecturer at Ain Shams University, teaching undergraduate biotechnology from 2018 to 2021. His contributions to neurobiology, proteomics, and molecular diagnostics have earned him a nomination for the Best Researcher Award. His dedication to research and mentoring, coupled with his global academic recognition, showcases his commitment to advancing the scientific community, making him a deserving candidate for further honors and accolades. 🌍🧬📚

Research Focus

Dr. Mohamed Taha’s research bridges molecular biology, neurodegeneration, and proteomics 🧬🧠. His Ph.D. work provided novel insights into Fragile X Mental Retardation Protein (FMRP), a key regulator of neuronal function and synaptic plasticity 💡. At NIH, he advanced proteomic approaches to analyze nuclear pore protein modifications during mitosis 🧫. Currently, he investigates oxidative stress and low-dose radiotherapy as therapeutic strategies for neurodegenerative diseases, especially Alzheimer’s 🧠⚡. He also explores genetic and biochemical markers in autism and viral diseases. His methodologies span CRISPR/Cas9 gene editing, confocal microscopy, flow cytometry, ELISA, FPLC protein purification, and real-time PCR 🔍. With a focus on translational research and early biomarker discovery, Dr. Taha’s work aims to bridge the gap between lab innovations and clinical applications, addressing unmet medical needs and contributing significantly to precision medicine 🌟🧪.

Publication Top Notes

  • Fragile X Messenger Ribonucleoprotein Protein and Its Multifunctionality: From Cytosol to Nucleolus and Back (Biomolecules, 2024)

  • 🦠 In Vitro Assessment of a Natural Monoterpene as an Antiviral Compound against Low Pathogenic Human Coronavirus 229E (Egypt. J. Chem., 2024)

  • 🔄 Physical Interaction between ERas and Arginase-1 in Quiescent Hepatic Stellate Cells (Cells, 2022)

  • 🧪 Telomere Length and Glutathione Level as Potential Biomarkers for Autism (J Psychi Res Rev Rep, 2021)

  • 🔗 Uncovering Multiple Protein Interaction Networks Linked to Fragile X Mental Retardation Protein (FEBS J., 2020)

  • 🛡️ FMRP Protects Against TNF-Mediated Cell Death and Liver Injury (Gut, 2020)

  • 📍 Subcellular Localization Reveals Direct Interaction of FMRP with Nucleolin (Manuscript)

Michael Keese | Medicine | Best Review Article Award

Assoc. Prof. Dr. Michael Keese | Medicine | Best Review Article Award 

Assoc. Prof. Dr. Michael Keese, TKH Mannheim, Germany

Assoc. Prof. Dr. Michael Keese is a distinguished researcher and educator at TKH Mannheim, Germany. He earned his doctorate (summa cum laude) in 1998 from the Biochemical Institute 2 at the University of Heidelberg. Following a decade of research and teaching at the University Medical Center Mannheim (UMM), he completed his habilitation. In 2013, he re-habilitated at the Medical Faculty of Goethe University Frankfurt and was appointed as an extraordinary professor in 2015. He rejoined UMM Mannheim in 2017 while continuing his teaching at the University Hospital Frankfurt. In 2023, he was appointed as a Visiting Professor at Baku State University, Azerbaijan.

Education:

Doctorate (PhD): Biochemical Institute 2, University of Heidelberg, Germany (1998) – Summa cum laude

Habilitation: University Medical Center Mannheim (UMM), Germany (after 10 years of research and teaching)

Re-habilitation: Medical Faculty, Goethe University Frankfurt, Germany (2013)

Professional Profiles:

ORCID Profile

Professional Experience:

Director, Department of Vascular and Endovascular Surgery, Theresienkrankenhaus and Diako Mannheim (since April 2022)

Visiting Professor, Baku State University, Azerbaijan (since November 2023)

Editor, Journal of Clinical Medicine (JCM) (since February 2023)

Head of Vascular Surgery, Universitätsmedizin Mannheim (2017–2022)

Head of Transplant Surgery, Universitätsmedizin Mannheim (2018–2022)

Deputy Clinic Director & Chief Senior Physician, Department of Vascular and Endovascular Surgery, Johann Wolfgang Goethe University Frankfurt (2015–2017)

Senior Physician & Head of Endovascular Surgery, Department of Vascular and Endovascular Surgery, Johann Wolfgang Goethe University Frankfurt (2011–2015)

Deputy Head, Vascular Surgery Section, Universitätsmedizin Mannheim (2010–2011)

Senior Physician, Department of Surgery, Universitätsmedizin Mannheim (2010–2011)

Specialist in Vascular Surgery, Universitätsmedizin Mannheim (2010)

Assistant Physician & Specialist in Surgery, Universitätsmedizin Mannheim (2004–2010)

Assistant Physician, Department of Surgery, Universitätsmedizin Mannheim (1999–2003)

Postdoctoral Researcher, EMBL Heidelberg (2003–2004)

Research Interests:

Establishment of novel imaging models for monitoring receptor tyrosine kinases

Contributions to the cell biology of mesenchymal stem cells, particularly their influence on vascular muscle cells and human umbilical vein endothelial cells (HUVECs)

siRNA and microRNA profiling of vascular smooth muscle cells (VSMCs) and endothelial cells

Top Notable Publications:

The Differentiation and Regeneration Potential of ABCB5+ Mesenchymal Stem Cells: A Review and Clinical Perspectives

Journal: Journal of Clinical Medicine

Date: 2025-01-21

DOI: 10.3390/jcm14030660

Contributors: Zheng He, Vytaute Starkuviene, Michael Keese

2. MTHFR Gene C677T Polymorphism (rs1801133) and Susceptibility to Colorectal Polyps in an Azerbaijani Population

Journal: Journal of Clinical Medicine

Date: 2023-12-30

DOI: 10.3390/jcm13010219

Contributors: Hazi Aslanov, Bayram Bayramov, Christoph Reissfelder, Shams Abdullayeva, Zeynab Mammadova, Fikrat Aliyev, Michael Keese, Javahir Hajibabazade, Vugar Yagublu

3. Adipose-Derived Mesenchymal Stem Cells Protect Endothelial Cells from Hypoxic Injury by Suppressing Terminal UPR In Vivo and In Vitro

Journal: International Journal of Molecular Sciences

Date: 2023-12-06

DOI: 10.3390/ijms242417197

Contributors: Michael Keese, Jiaxing Zheng, Kaixuan Yan, Karen Bieback, Benito A. Yard, Prama Pallavi, Christoph Reissfelder, Mark Andreas Kluth, Martin Sigl, Vugar Yagublu

4. A Systematic Review and Bayesian Network Meta-Analysis on the Effect of Different Anticoagulants on the Prophylaxis of Post-Thrombotic Syndrome after Deep Venous Thrombosis

Journal: Journal of Clinical Medicine

Date: 2023-11-30

DOI: 10.3390/jcm12237450

Contributors: Jingbo Shao, Qianwen Zhou, Fukang Jin, Christoph Reissfelder, Martin Sigl, Vugar Yagublu, Michael Keese

5. Comparison of Tumour-Specific Phenotypes in Human Primary and Expandable Pancreatic Cancer Cell Lines

Journal: International Journal of Molecular Sciences

Date: 2023-08

DOI: 10.3390/ijms241713530

Contributors: Feng Guo, Kejia Kan, Felix Rückert, Wolfgang Rückert, Lin Li, Johannes Eberhard, Tobias May, Carsten Sticht, Wilhelm Gerhard Dirks, Christoph Reissfelder et al.

6. Analysis of Inflammation-Related Genes in Patients with Stanford Type A Aortic Dissection

Journal: Journal of Personalized Medicine

Date: 2023-06-13

DOI: 10.3390/jpm13060990

Contributors: Lin Li, Ziwei Zeng, Vugar Yagublu, Nuh Rahbari, Christoph Reißfelder, Michael Keese

7. Investigation of Different Methods of Intraoperative Graft Perfusion Assessment during Kidney Transplantation for the Prediction of Delayed Graft Function: A Prospective Pilot Trial

Journal: Journal of Personalized Medicine

Date: 2022-10

DOI: 10.3390/jpm12101749

Contributors: Andreas Gerken, Michael Keese, Christel Weiss, Hanna-Sophie Krücken, Katarina A. P. Pecher, Augusto Ministro, Nuh N. Rahbari, Christoph Reissfelder, Ulrich Rother, Babak Yazdani et al.

Conclusion:

Assoc. Prof. Dr. Michael Keese is a strong contender for the “Best Review Article Award.” His significant contributions to advancing stem cell research, particularly in the differentiation and regenerative potential of ABCB5+ mesenchymal stem cells, align well with the objectives of this award. His work is not only well-regarded in academic circles but also demonstrates the potential to improve clinical applications, making it highly relevant to current scientific and medical challenges.

 

Giulia Passaniti | Medicine | Best Review Article Award

Dr. Giulia Passaniti | Medicine | Best Review Article Award

Dr. Giulia Passaniti, Centro Alte Specialità e Trapianti- Policlinico G. Rodolico- San Marco, Italy

Dr. Giulia Passaniti is a highly accomplished medical professional specializing in cardiovascular imaging and structural heart interventions. She is currently pursuing an Imaging Fellowship for Structural Heart Interventions at Mount Sinai Hospital, New York (2023-2024). Dr. Passaniti has also completed advanced training in Stress, Transesophageal, and Advanced Echocardiography at the Azienda Ospedaliera Università di Padova, where she earned a Second-Level Master’s Degree with Summa Cum Laude (2022-2023).

Education:

Imaging Fellowship for Structural Heart Interventions

Institution: Mount Sinai Hospital, New York

Duration: 07/01/2023 – 06/30/2024

Stress, Transesophageal, and Advanced Echocardiography

Institution: Azienda Ospedaliera Università di Padova – Cardiovascular Disease Department

Degree: Second-Level Master’s Degree

Duration: 11/01/2022 – 09/22/2023

Honors: Graduated Summa cum laude

Cardiovascular Diseases Fellowship

Institution: Azienda Ospedaliera Universitaria Policlinico “G. Rodolico”, Catania, Italy

Duration: 01/26/2021 – 01/26/2025

Clinical Clerkship

Institution: Policlinico “G. Rodolico”, Catania, Italy

Duration: 10/01/2018 – 01/31/2019

Medical Education (Doctor of Medicine – MD)

Institution: Facoltà di Medicina e Chirurgia, Università di Catania

Duration: 10/06/2012 – 07/18/2018

Honors: Graduated Summa cum laude on 07/18/2018

Professional Profiles:

ORCID Profile

Google Scholar

Professional Experience:

Dr. Giulia Passaniti has gained extensive medical experience through various roles in Italy’s healthcare system. From February 2020 to December 2020, she served as a Medical Doctor at Centro Alte Specialità e Trapianti- Policlinico G. Rodolico- San Marco, where she contributed to specialized medical care and transplant-related services. Prior to this, from November 2019 to February 2020, she worked at Centro Multispecialistico Etneo, gaining experience in a multidisciplinary clinical setting. Additionally, she provided medical care at Guardia Medica of Aci Sant’Antonio from November 2019 to February 2020 and at Guardia Medica of Pedara from July 2019 to September 2019, where she was responsible for emergency medical assistance and primary healthcare services. Her diverse clinical background highlights her ability to adapt to different medical environments and provide high-quality patient care.

Top Notable Publications:

Role of advanced cardiovascular imaging in chemotherapy-induced cardiotoxicity
Heliyon, 2023
Contributors: MT Cannizzaro, MC Inserra, G Passaniti, A Celona, T D’Angelo, P Romeo, et al.

Pulmonary hypertension
Novel Pathogenesis and Treatments for Cardiovascular Disease, 2022
Contributors: M Mulè, G Passaniti, D Giannazzo

MR imaging of primary benign cardiac tumors in the pediatric population
Heliyon, 2023
Contributors: MC Inserra, MT Cannizzaro, G Passaniti, A Celona, A Secinaro, et al.

Transcatheter Edge-to-Edge Approach to Repair Large Coaptation Gaps: The Zipping Technique
Cardiovascular Interventions, 2024
Contributors: G Passaniti, GHL Tang, R Tanner, SK Sharma, AS Kini, S Lerakis

Do we still need intra-procedural TTE during Transcatheter aortic valve replacement? A high volume, single center experience
Cardiovascular Revascularization Medicine, 2024
Contributors: YN Granot, G Passaniti, FR Prandi, SK Sharma, A Kini, S Lerakis

Echo HALT: do we really need a cardiac CT?
The International Journal of Cardiovascular Imaging, 2024
Contributors: G Passaniti, FR Prandi, S Sharma, A Kini, S Lerakis

Fundamental Roles of Intracardiac Echocardiography and Fluoroscopy in Redo Tricuspid Transcatheter Edge-to-Edge Repair Procedure
Cardiovascular Interventions, 2024
Contributors: G Passaniti, LM Safi, F Prandi, S Ratanapo, S Lerakis, GHL Tang, et al.

IMPACT OF AORTIC VALVE CALCIFICATION SEVERITY IN PATIENTS WITH LOW-FLOW LOW-GRADIENT AORTIC STENOSIS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT
Journal of the American College of Cardiology, 2024
Contributors: R Singh, L Chopra, D Sperling, A Dalsania, H Ueyama, FR Prandi, et al.

Imaging in a Rare Case of Neonatal Arterial Tortuosity Syndrome
Global Medical Genetics, 2023
Contributors: MC Inserra, A Di Mari, G Passaniti, MT Cannizzaro, G La Rosa, D Poli, et al.

Myocardial fibrosis in aortic stenosis: Comparison between clinical data, laboratory, echocardiography, and cardiac magnetic resonance
Journal of Cardiology and Cardiovascular Medicine, 2023
Contributors: G Tosto, G Passaniti, FA Gibiino, W Deste, A Indelicato, T Torrisi, et al.

Conclusion:

Dr. Giulia Passaniti is a highly suitable candidate for the Research for Best Review Article Award due to her expertise in cardiovascular imaging, extensive collaborations, and high-quality publications. Strengthening her focus on systematic reviews and increasing outreach efforts could further solidify her eligibility for this prestigious recognition.